Theriva Biologics (TOVX) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-10.75
-5.16
0.44
6.03

Details

Expected EPS
-4.19
Actual EPS
-1.55
Surprise EPS
2.64
Surprise Percent
+63.01%

Description

Theriva Biologics (TOVX) has reported earnings of -1.55 per share for Q2 2025.

0 Comments

Share your thoughts